These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 32432777)
1. A novel orexin antagonist from a natural plant was discovered using zebrafish behavioural analysis. Yamanaka M; Iwata H; Masuda K; Araki M; Okuno Y; Okamura M; Koiwa J; Tanaka T Eur Rev Med Pharmacol Sci; 2020 May; 24(9):5127-5139. PubMed ID: 32432777 [TBL] [Abstract][Full Text] [Related]
2. Crystal structure of the human OX2 orexin receptor bound to the insomnia drug suvorexant. Yin J; Mobarec JC; Kolb P; Rosenbaum DM Nature; 2015 Mar; 519(7542):247-50. PubMed ID: 25533960 [TBL] [Abstract][Full Text] [Related]
3. [Preclinical and clinical results of dual orexin receptor antagonist, suvorexant (BELSOMRA(®)), a novel therapeutic agent for insomnia]. Tanaka Y; Aoki I; Ishine T; Renger JJ; Winrow CJ; Hisada S Nihon Yakurigaku Zasshi; 2016 Jul; 148(1):46-56. PubMed ID: 27430679 [No Abstract] [Full Text] [Related]
4. Structure and ligand-binding mechanism of the human OX1 and OX2 orexin receptors. Yin J; Babaoglu K; Brautigam CA; Clark L; Shao Z; Scheuermann TH; Harrell CM; Gotter AL; Roecker AJ; Winrow CJ; Renger JJ; Coleman PJ; Rosenbaum DM Nat Struct Mol Biol; 2016 Apr; 23(4):293-9. PubMed ID: 26950369 [TBL] [Abstract][Full Text] [Related]
5. The Discovery of Suvorexant, the First Orexin Receptor Drug for Insomnia. Coleman PJ; Gotter AL; Herring WJ; Winrow CJ; Renger JJ Annu Rev Pharmacol Toxicol; 2017 Jan; 57():509-533. PubMed ID: 27860547 [TBL] [Abstract][Full Text] [Related]
6. Suvorexant, an orexin/hypocretin receptor antagonist, attenuates motivational and hedonic properties of cocaine. Gentile TA; Simmons SJ; Barker DJ; Shaw JK; España RA; Muschamp JW Addict Biol; 2018 Jan; 23(1):247-255. PubMed ID: 28419646 [TBL] [Abstract][Full Text] [Related]
14. Suvorexant as an orexin antagonist may regulate serum glucose levels in psychiatric patients with insomnia. Nakamura M; Nagamine T Psychiatry Clin Neurosci; 2017 Dec; 71(12):844. PubMed ID: 28945327 [No Abstract] [Full Text] [Related]
15. Failure of the dual orexin receptor antagonist suvorexant to engender drug discrimination in rats. Steiner MA; Toeroek-Schafroth M; Dacome L; Tessari M J Psychopharmacol; 2023 Dec; 37(12):1261-1264. PubMed ID: 37982383 [TBL] [Abstract][Full Text] [Related]
16. Preclinical assessment of the abuse potential of the orexin receptor antagonist, suvorexant. Born S; Gauvin DV; Mukherjee S; Briscoe R Regul Toxicol Pharmacol; 2017 Jun; 86():181-192. PubMed ID: 28279667 [TBL] [Abstract][Full Text] [Related]